Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 21.6824.8716.1331.1828.05

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 21.68 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202521.68
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 21.68
-12.83
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹31,269.2 Cr 12.4% 10.6% 23.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹105,961.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -3.4% -5.7% 0.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

12.4%

10.6%

23.7%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses